If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
90.00    0.00 (0.00%)
Bid:
85.00
Ask:
95.00
Spread: 10.00 (11.765%)
Market Cap: £5.92m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Multiyear contract win with major wholesaler

19 Jul 2022 07:00

RNS Number : 8820S
Crimson Tide PLC
19 July 2022
 

19 July 2022

Crimson Tide plc

("Crimson Tide" or "the Company")

 

Multiyear contract win with major wholesaler

 

 

Crimson Tide Plc (TIDE), the provider of the mpro5 solution, is pleased to announce a significant new long term contract win with a major UK wholesaler. The new client will be using Crimson Tide's mpro5 solution to digitalise processes across its entire estate of over 190 stores in the UK. The initial term of the agreement is for 3 years, with a total value in excess of £550k.

 

Logbooks form the backbone of evidencing compliance in the wholesale and retail sector. To date, the wholesaler has relied on traditional logbooks, making it very difficult to verify and learn from key data across its business operations.

 

Transferring from paper to digital will give the client improved visibility and real time insight into its business data, giving management teams the ability to respond to data highlighting non-compliance quickly and effectively. This is a typical example of how the mpro5 platform can help drive efficiencies and revolutionise operating procedures.

 

Barrie Whipp, Chairman, commented: "I am particularly pleased that one of the UK's most respected wholesalers has decided to partner with us in this long-term contract, which builds on our existing strength in the sector. mpro5 continues to prove to be a great solution for organisations looking to make use of the multifaceted capabilities of our platform. Our ability to provide this new client with dramatically improved insight into its operations, further evidences the diverse and flexible nature of the mpro5 platform. The contract is another building block in our growing annual recurring revenue."

 

 

For further information, please contact:

 

Crimson Tide plc

Via Alma PR

Barrie Whipp / Luke Jeffrey

01892 542 444

finnCap (Nominated adviser and Broker)

Corporate Finance: Julian Blunt / James Thompson

 +44 20 7220 0500

Corporate Broking: Andrew Burdis

+44 20 7220 0500

Alma PR - (Financial PR)

Josh Royston / Will Ellis Hancock

+44 7780 901 979

 

For further information on Crimson Tide plc, see www.crimsontide.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTUWRBRUVUBAAR
Date   Source Headline
7th Mar 202512:23 pmRNSForm 8.3 - Crimson Tide plc
7th Mar 202510:20 amRNSForm 8.5 (EPT/RI)
6th Mar 20259:22 amRNSForm 8.5 (EPT/NON-RI)
5th Mar 202511:07 amRNSForm 8.5 (EPT/RI)
4th Mar 20254:48 pmRNSForm 8.3 - Crimson Tide PLC
4th Mar 202510:00 amRNSForm 8.5 (EPT/RI)
3rd Mar 202512:13 pmRNSForm 8.5 (EPT/RI)
27th Feb 202511:07 amRNSForm 8.5 (EPT/RI)
26th Feb 20254:42 pmRNSForm 8.3 - Crimson Tide plc
26th Feb 20254:11 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
26th Feb 20252:09 pmRNSForm 8.3 - Crimson Tide PLC
26th Feb 20258:34 amRNSForm 8.5 (EPT/NON-RI)
25th Feb 20253:00 pmRNSForm 8.3 - Crimson Tide PLC
25th Feb 202511:51 amRNSForm 8.5 (EPT/NON-RI) - Amendment
25th Feb 202511:33 amRNSForm 8.5 (EPT/RI)
24th Feb 202511:52 amRNSForm 8.5 (EPT/RI)
24th Feb 202510:42 amRNSForm 8.3 - Crimson Tide plc
21st Feb 202510:30 amRNSForm 8.3 - Crimson Tide plc - Replacement
20th Feb 20252:08 pmGNWForm 8.3 - Crimson Tide Plc
20th Feb 20252:00 pmRNSForm 8.3 - Crimson Tide plc
20th Feb 202511:33 amRNSForm 8.3 - CRIMSON TIDE PLC
20th Feb 202510:39 amRNSForm 8.5 (EPT/RI)
20th Feb 20259:27 amRNSForm 8.5 (EPT/RI)
20th Feb 20257:00 amRNSPublication of Circular
20th Feb 20257:00 amRNSPublication of Scheme Document
19th Feb 20254:47 pmGNWForm 8.3 - Crimson Tide plc - Octopus Investments
19th Feb 20254:30 pmRNSForm 8 (OPD) - Crimson Tide plc
19th Feb 20253:11 pmRNSForm 8.3 - Crimson Tide Plc
19th Feb 20252:22 pmRNSForm 8.3 - Crimson Tide PLC
19th Feb 202510:47 amRNSForm 8.5 (EPT/RI)
18th Feb 20254:01 pmRNSForm 8.3 - Crimson Tide Plc
17th Feb 20253:39 pmRNSForm 8.3 - Crimson Tide PLC
17th Feb 202510:04 amRNSForm 8.3 - Crimson Tide Plc
14th Feb 202510:38 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20251:22 pmRNSForm 8.3 - Crimson Tide Plc
13th Feb 202511:47 amRNSForm 8.5 (EPT/RI)
12th Feb 20252:36 pmGNWForm 8.3 - Crimson Tide Plc
12th Feb 20251:12 pmGNWForm 8.3 - [CRIMSON TIDE PLC - Opening Disclosure - 11 02 2025] - (CGAML)
12th Feb 202511:23 amRNSForm 8.3 - Crimson Tide plc
12th Feb 202510:45 amRNSForm 8.5 (EPT/RI)
12th Feb 20258:59 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20257:00 amRNSRecommended All-Share Merger with Crimson Tide
14th Nov 20243:32 pmRNSHolding(s) in Company
14th Nov 20243:25 pmRNSPDMR Dealing
26th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSCrimson Tide Launches Interactive Investor Hub
30th Jul 20247:00 amRNSBoard Changes
11th Jul 20241:07 pmRNSStatement of no intention to make an offer
9th Jul 20248:20 amRNSForm 8.5 (EPT/NON-RI)
27th Jun 20242:45 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.